Evermay Wealth Management LLC bought a new position in shares of Stryker Corporation (NYSE:SYK) in the fourth quarter, HoldingsChannel reports. The firm bought 1,305 shares of the medical technology company’s stock, valued at approximately $202,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Coldstream Capital Management Inc. grew its stake in shares of Stryker by 3.7% during the 2nd quarter. Coldstream Capital Management Inc. now owns 17,445 shares of the medical technology company’s stock worth $2,421,000 after acquiring an additional 626 shares in the last quarter. Retirement Systems of Alabama grew its stake in shares of Stryker by 2.5% during the 3rd quarter. Retirement Systems of Alabama now owns 234,870 shares of the medical technology company’s stock worth $33,356,000 after acquiring an additional 5,656 shares in the last quarter. Toronto Dominion Bank grew its stake in shares of Stryker by 25.8% during the 2nd quarter. Toronto Dominion Bank now owns 105,403 shares of the medical technology company’s stock worth $14,625,000 after acquiring an additional 21,585 shares in the last quarter. Colonial Trust Advisors grew its stake in shares of Stryker by 56.1% during the 2nd quarter. Colonial Trust Advisors now owns 23,446 shares of the medical technology company’s stock worth $3,254,000 after acquiring an additional 8,426 shares in the last quarter. Finally, Cornerstone Capital Management Holdings LLC. grew its stake in shares of Stryker by 3.1% during the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 55,255 shares of the medical technology company’s stock worth $7,847,000 after acquiring an additional 1,683 shares in the last quarter. 74.71% of the stock is owned by institutional investors and hedge funds.

In other Stryker news, VP William E. Berry, Jr. sold 1,306 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $164.42, for a total transaction of $214,732.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Graham A. Mclean sold 2,984 shares of the firm’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $160.53, for a total value of $479,021.52. Following the sale, the insider now directly owns 9,100 shares of the company’s stock, valued at approximately $1,460,823. The disclosure for this sale can be found here. Insiders have sold a total of 16,840 shares of company stock valued at $2,749,989 in the last ninety days. Insiders own 7.40% of the company’s stock.

Several equities analysts have recently weighed in on the stock. Oppenheimer set a $156.00 price target on shares of Stryker and gave the stock a “hold” rating in a research note on Monday, October 30th. Canaccord Genuity raised their price target on shares of Stryker from $155.00 to $162.00 and gave the stock a “buy” rating in a research note on Friday, October 27th. Zacks Investment Research cut shares of Stryker from a “hold” rating to a “sell” rating in a research note on Monday, October 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker in a research note on Wednesday, January 17th. Finally, Robert W. Baird raised shares of Stryker from a “neutral” rating to an “outperform” rating in a research note on Friday, November 24th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $162.50.

Stryker Corporation (SYK) opened at $153.66 on Tuesday. Stryker Corporation has a 52 week low of $123.34 and a 52 week high of $170.00. The company has a quick ratio of 1.59, a current ratio of 2.29 and a debt-to-equity ratio of 0.66. The firm has a market cap of $56,653.36, a price-to-earnings ratio of 23.30, a P/E/G ratio of 2.17 and a beta of 0.70.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share for the quarter, beating the consensus estimate of $1.95 by $0.01. Stryker had a net margin of 8.20% and a return on equity of 24.56%. The business had revenue of $3.47 billion during the quarter, compared to analysts’ expectations of $3.42 billion. During the same period last year, the business earned $1.78 earnings per share. The firm’s revenue was up 9.9% on a year-over-year basis. research analysts anticipate that Stryker Corporation will post 7.12 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, April 30th. Shareholders of record on Thursday, March 29th will be issued a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a yield of 1.22%. The ex-dividend date of this dividend is Wednesday, March 28th. Stryker’s dividend payout ratio is 70.15%.

ILLEGAL ACTIVITY NOTICE: “Evermay Wealth Management LLC Buys Shares of 1,305 Stryker Corporation (SYK)” was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://www.watchlistnews.com/evermay-wealth-management-llc-buys-shares-of-1305-stryker-corporation-syk/1863452.html.

Stryker Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.